Formo receives FDA no-questions letter for precision fermentation casein
Formo said it received a no-questions letter from the US Food and Drug Administration for its animal-free casein made through precision fermentation. The Berlin-based company said the ingredient is intended for dairy alternatives and that it plans to scale production with partners in Europe.
Why it matters: A precision fermentation company clearing a US regulatory step for animal-free casein, with European scale-up next.